Fenofibrate and Lactobacillus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fenofibrate (fenofibrate) and Lactobacillus (lactobacillus). Common drug interactions include pneumonia aspiration among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Fenofibrate and Lactobacillus. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Lactobacillus?

Lactobacillus has active ingredients of lactobacillus. It is often used in stomach discomfort. eHealthMe is studying from 5,854 Lactobacillus users. Check the latest studies of Lactobacillus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

59 people who take Fenofibrate and Lactobacillus together, and have interactions are studied.

Fenofibrate and Lactobacillus drug interactions.

What are the common drug interactions of Fenofibrate and Lactobacillus, by gender? *:

female:

  1. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  2. Seasonal allergy (allergic condition due to certain season)
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Abdominal pain
  5. Agitation (state of anxiety or nervous excitement)
  6. Anxiety
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  9. Confusional state
  10. Deafness

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Fatigue (feeling of tiredness)
  3. Injury
  4. Nephrolithiasis (calculi in the kidneys)
  5. Neuropathy peripheral (surface nerve damage)
  6. Pneumonia
  7. Rash
  8. Renal impairment (severely reduced kidney function)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Urinary tract infection

What are the common drug interactions of Fenofibrate and Lactobacillus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Depression
  2. Muscle spasms (muscle contraction)

50-59:

  1. Pneumonia
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Obstructive uropathy (a blockage that prevents urine from leaving your kidneys)
  6. Abdominal distension
  7. Arthralgia (joint pain)
  8. Back pain
  9. Blood creatinine increased
  10. Chronic kidney disease

60+:

  1. Urinary tract infection
  2. Joint swelling
  3. Confusional state
  4. Constipation
  5. Cystitis (inflammation of the wall of the bladder)
  6. Deafness
  7. Decreased appetite
  8. Dementia (madness)
  9. Depressed mood
  10. Dizziness

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 7 people, 11.86%
  2. Pain: 7 people, 11.86%
  3. High Blood Pressure: 7 people, 11.86%
  4. Combined Immunodeficiency: 6 people, 10.17%
  5. Diarrhea: 5 people, 8.47%
  6. Stress And Anxiety: 4 people, 6.78%
  7. Depression: 4 people, 6.78%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 6.78%
  9. Chest Pain: 4 people, 6.78%
  10. Insomnia (sleeplessness): 4 people, 6.78%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and Lactobacillus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fenofibrate and Lactobacillus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lactobacillus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fenofibrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lactobacillus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate and lactobacillus (the active ingredients of Fenofibrate and Lactobacillus, respectively), and Fenofibrate and Lactobacillus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: